News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

INFORMS Applauds Passage of Historic Legislation to Modernize STEM Education
News Release

BALTIMORE, MD, September 26, 2024 – In overwhelming bipartisan fashion, the U.S. House of Representatives just passed the “Mathematical and Statistical Modeling Education Act,” (H.R. 1735) which, if enacted, would modernize STEM education in the United States. The bill passed by unanimous consent.

Read More
Closing the Racial Gap in CRC: Screening is Just the First Step
Media Coverage

Too many people in the United States are dying of colorectal cancer (CRC). The #2 cancer killer in the United States, it impacts Black Americans disproportionately. Compared to White adults, Black adults aged 50 and above get colon cancer at a rate that’s 23% higher than White adults and have a 31% higher risk of dying from the disease.1 These disparities persist despite progress in screening and treatment and are particularly frustrating because CRC is highly treatable when caught in early stages and even preventable when pre-cancers are identified and removed through screening. These differences in incidence and mortality persist even while we have made progress to make screening more accessible to all. A 2019 NIH study showed that a similar proportion of Black and White Americans are up to date with CRC screening2, a meaningful improvement since 20053. If screening access and uptake are now so similar, why do these disparities persist?  

Read More
Big Government and Big Tech both want your biometric data
Media Coverage

Both Amazon and the Transportation Security Administration (TSA) are demanding the biometric data of all Americans.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
NITIE, Mumbai successfully completes the 30 Hour Global Online Certification Course on Supply Chain Digitization and Management for 2500+ Participants

NITIE, Mumbai successfully completes the 30 Hour Global Online Certification Course on Supply Chain Digitization and Management for 2500+ Participants

The Economic Times, April 17, 2021

Shri Nitin Gadkari, Honourable Union Minister for Road Transport & Highways Micro, Small and Medium Enterprises - Government of India presided as Chief Guest of Honour for the virtual Closing Ceremony of the Global Online Certification Course on Supply Chain Digitization and Management, that was conducted by the National Institute of Industrial Engineering (NITIE), Mumbai. The closing ceremony marked the completion of the immensely successful virtual course that was launched in January, 2.

IHI and DAISY Foundation™ Honor Nursing Professionals

IHI and DAISY Foundation™ Honor Nursing Professionals

Businesswire, April 15, 2021

BOSTON--(BUSINESS WIRE)--The Institute for Healthcare Improvement (IHI) and the DAISY Foundation have announced the recipients of the 2021 DAISY Awards for Extraordinary Nurses in Patient Safety, presented in collaboration with IHI. Christa Bedford-Mu, MSN, RN, CNS, CCRN, C-ELBW, receives the individual award. Co-recipients of the team award include the ICU Nursing Team at Swedish Edmonds hospital and the Faith Community Nurses Team at Emory Saint Joseph’s Hospital.

What Experts Are Saying About the Johnson & Johnson Vaccine Pause

What Experts Are Saying About the Johnson & Johnson Vaccine Pause

New York Magazine, April 14, 2021

On Tuesday, the FDA and CDC recommended pausing the administration of the Johnson & Johnson COVID vaccine while the agencies investigate an extremely rare possible side effect. Six women in the U.S. who received the J&J vaccine — all between the ages of 18 and 28 — experienced a blood- clotting disorder called cerebral venous sinus thrombosis in the days after getting their shots, and one has died. It’s not yet clear if the clots were related to the vaccine, though a similar disorder has occurred abroad among some recipients of the AstraZeneca COVID vaccine, which uses the same adenovirus-vector technology as Johnson & Johnson’s. As scientists continue to research the cases to determine if and how they may be related to the shot, U.S. regulators’ sudden decision to pause J&J’s distribution has prompted widespread reaction from across the COVID-expert community. Below is an overview of what they are saying.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine